X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/03/06/2841353/0/en/Avalyn-to-Participate-in-Leerink-Partners-Global-Biopharma-Conference.html
https://www.globenewswire.com//news-release/2024/02/06/2824272/0/en/Avalyn-to-Participate-in-Multiple-Upcoming-Investor-Conferences.html
https://www.globenewswire.com/news-release/2023/12/06/2791709/0/en/Avalyn-to-Participate-in-the-2023-RBC-Capital-Markets-Healthcare-Private-Company-Conference.html
https://www.globenewswire.com//news-release/2023/11/09/2777290/0/en/Avalyn-Presents-Data-from-its-AP01-and-AP02-Inhaled-Therapeutics-Programs-for-Pulmonary-Fibrosis.html
https://www.globenewswire.com//news-release/2023/11/06/2774069/0/en/Avalyn-Strengthens-Leadership-Team-with-Key-Appointments-including-Dr-Craig-Conoscenti-as-SVP-Clinical-Development-and-Jim-Bishop-as-SVP-Business-Operations.html
https://www.globenewswire.com//news-release/2023/10/05/2755333/0/en/Avalyn-to-Participate-in-Multiple-Upcoming-Investor-Conferences.html
https://www.globenewswire.com//news-release/2023/09/29/2751857/0/en/Avalyn-to-Provide-Keynote-Presentation-at-the-Formulation-Delivery-U-S-2023-Conference.html
https://endpts.com/avalyn-raises-175m-to-test-inhaler-versions-of-ipf-medicines-in-phii-trials/
https://www.globenewswire.com//news-release/2023/09/27/2750197/0/en/Avalyn-Raises-175-Million-in-Oversubscribed-Series-C-Financing-to-Advance-Inhaled-Pulmonary-Fibrosis-Programs-into-Later-Stage-Clinical-Studies.html
https://www.globenewswire.com//news-release/2023/09/18/2745075/0/en/Avalyn-Pharma-s-CEO-Leads-Workshop-on-Clinical-Strategy-at-IPF-Summit.html
Market Place
Share 
